These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11849694)

  • 21. Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5.
    Sarrazin C; Gärtner BC; Sizmann D; Babiel R; Mihm U; Hofmann WP; von Wagner M; Zeuzem S
    J Clin Microbiol; 2006 Mar; 44(3):729-37. PubMed ID: 16517847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serum.
    Trimoulet P; Halfon P; Pohier E; Khiri H; Chêne G; Fleury H
    J Clin Microbiol; 2002 Jun; 40(6):2031-6. PubMed ID: 12037059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A reverse-transcription competitive PCR assay based on chemiluminescence hybridization for detection and quantification of hepatitis C virus RNA.
    Young KC; Chang TT; Hsiao WC; Cheng PN; Chen SH; Jen CM
    J Virol Methods; 2002 May; 103(1):27-39. PubMed ID: 11906730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays.
    Konnick EQ; Williams SM; Ashwood ER; Hillyard DR
    J Clin Microbiol; 2005 May; 43(5):2133-40. PubMed ID: 15872232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications.
    Gretch DR; dela Rosa C; Carithers RL; Willson RA; Williams B; Corey L
    Ann Intern Med; 1995 Sep; 123(5):321-9. PubMed ID: 7542853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of an automated system for quantitation of hepatitis C virus core antigen.
    Saito R; Yokota H; Takahashi E; Mashige F; Yoneyama A; Nakahara K; Okamura N
    J Virol Methods; 2003 Sep; 112(1-2):93-7. PubMed ID: 12951216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA).
    Elbeik T; Surtihadi J; Destree M; Gorlin J; Holodniy M; Jortani SA; Kuramoto K; Ng V; Valdes R; Valsamakis A; Terrault NA
    J Clin Microbiol; 2004 Feb; 42(2):563-9. PubMed ID: 14766817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of genotypes on the quantification of hepatitis C virus (HCV) RNA in clinical samples using the Amplicor HCV Monitor Test and the Quantiplex HCV RNA 2.0 assay (bDNA).
    Tong CY; Hollingsworth RC; Williams H; Irving WL; Gilmore IT
    J Med Virol; 1998 Jul; 55(3):191-6. PubMed ID: 9624605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic range of hepatitis C virus RNA quantification with the Cobas Ampliprep-Cobas Amplicor HCV Monitor v2.0 assay.
    Gourlain K; Soulier A; Pellegrin B; Bouvier-Alias M; Hézode C; Darthuy F; Rémiré J; Pawlotsky JM;
    J Clin Microbiol; 2005 Apr; 43(4):1669-73. PubMed ID: 15814982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
    Trabaud MA; Bailly F; Si-Ahmed SN; Chevallier P; Sepetjan M; Colucci G; Trépo C
    J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient reappearance of serum hepatitis C virus RNA observed by real-time PCR during antiviral therapy with peginterferon and ribavirin in patients with HCV genotype 1b.
    Toyoda H; Kumada T; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Tada T; Takagi M; Hiramatsu T; Hosokawa T; Arakawa T; Fujimori M
    J Clin Virol; 2010 Mar; 47(3):258-62. PubMed ID: 20116330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
    Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
    J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy.
    Takahashi M; Saito H; Higashimoto M; Atsukawa K; Ishii H
    J Clin Microbiol; 2005 Jan; 43(1):186-91. PubMed ID: 15634970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of a competitive combined reverse transcription-PCR assay with a branched-DNA assay for hepatitis C virus RNA quantitation.
    Mayerat C; Bürgisser P; Lavanchy D; Mantegani A; Frei PC
    J Clin Microbiol; 1996 Nov; 34(11):2702-6. PubMed ID: 8897168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA.
    Alter HJ; Sanchez-Pescador R; Urdea MS; Wilber JC; Lagier RJ; Di Bisceglie AM; Shih JW; Neuwald PD
    J Viral Hepat; 1995; 2(3):121-32. PubMed ID: 7493306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
    De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of two Real-Time RT-PCR assays for quantitation of hepatitis C virus RNA: evaluation on HCV genotypes 1-4.
    Elkady A; Tanaka Y; Kurbanov F; Sugauchi F; Sugiyama M; Khan A; Ali EM; Mouhamed L; Abou el-fetouh S; AbdEl-Hameed AR; Mizokami M
    J Med Virol; 2010 Nov; 82(11):1878-88. PubMed ID: 20872714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical performance of the LCx HCV RNA quantitative assay.
    Bertuzis R; Hardie A; Hottentraeger B; Izopet J; Jilg W; Kaesdorf B; Leckie G; Leete J; Perrin L; Qiu C; Ran I; Schneider G; Simmonds P; Robinson J
    J Virol Methods; 2005 Feb; 123(2):171-8. PubMed ID: 15620399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of the COBAS AMPLICOR HCV MONITOR test, version 2.0, an automated reverse transcription-PCR quantitative system for hepatitis C virus load determination.
    Gerken G; Rothaar T; Rumi MG; Soffredini R; Trippler M; Blunk MJ; Butcher A; Soviero S; Colucci G
    J Clin Microbiol; 2000 Jun; 38(6):2210-4. PubMed ID: 10834978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative assays for hepatitis C virus in serum as predictors of the long-term response to interferon.
    Shiratori Y; Kato N; Yokosuka O; Hashimoto E; Hayashi N; Nakamura A; Asada M; Kuroda H; Ohkubo H; Arakawa Y; Iwama A; Omata M
    J Hepatol; 1997 Sep; 27(3):437-44. PubMed ID: 9314119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.